Despite improved treatment for HIV disease and FDA approved pre-exposure prophylaxis
(PrEP) for HIV prevention in 2012, Washington DC continues to be an endemic city with
an overall prevalence of 1.9% and 41% of new infections occurring in youth; almost
double the national rate. The interest and uptake of PrEP in youth has been relatively
understudied to date. This study sought to document the current level of awareness
about and willingness to take PrEP in a sample of urban youth from our patient community,
as well as changes in awareness between 2012 and 2018.
To read this article in full you will need to make a payment
Purchase one-time access:
Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online accessOne-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
Subscribe:
Subscribe to Journal of Pediatric and Adolescent GynecologyAlready a print subscriber? Claim online access
Already an online subscriber? Sign in
Register: Create an account
Institutional Access: Sign in to ScienceDirect
